Drexel licensee DecisionSim secures $1.85m in series A for simulation-based learning platforms.
DecisionSim, a startup which has licensed technology from Drexel University, has secured $1.85m in its series A.
The cash comes from Rittenhouse Ventures, which provided $1.5m, and early-stage investor Ben Franklin Technology Partners of Southeastern Pennsylvania, which provided the remainder.
DecisionSim will be using the funding to develop its healthcare focused simulation-based learning platform, which utilises communications training technology licensed from Drexel’s College of Medicine.
Bob Yayac, CEO of DecisionSim, said: “The new capital will benefit both existing and future clients by enabling us to enhance our simulation platforms, and will also allow us to expand into emerging growth areas such as life sciences and managed care. We are seeing high demand for DecisionSim from health organizations due to increasing pressure on them to deliver better quality, cost effective patient-care, and now we can offer even more value to these clients.”
